… with resistance to hormonal therapy. Experimental evidence … therapeutic target and a
predictive biomarker for ER+ breast cancer patients at high risk for resistance to hormonal therapy …

… of EVs in body fluids as clinically useful diagnostic and prognostic biomarkers. In this review,
… EVs as biomarkers and therapeutic targets and discuss their potential clinical applications. …

… biomarkers for early diagnosis, prognosis and assessment of liver diseases and discuss the
challenges in miRNA-based therapy … and may identify biomarkers and therapeutic targets for …

… , no biomarkers for stroke are available to use in clinical … , identification of therapeutic targets
and biomarker discovery. … stroke and the current status of biomarker research in stroke. We …

… Furthermore, as ICB and CAR-T cells have been the most rigorously evaluated immunotherapy
strategies in the clinic, we will also discuss biomarkers associated with the clinical …

… as prognostic biomarkers. We also describe potential therapeutic strategies to target Tregs
in … to overcome tumor resistance and improve clinical outcomes in cancer patients. Overall, …

… with potential circulating biomarkers and therapeutic targets for a host of human diseases. …
up their investigation in liquid biopsies as sources of biomarkers and therapeutic targets. …

… These data indicate the potential for circRNAs being developed as novel biomarkers or/and
therapeutic targets for the diagnosis and progression of squamous cell cancers (Table ​1, …

… , is the primary therapeutic target for … therapeutic target in clinical practice. Ongoing coronary
artery disease residual risk, despite lipid-lowering treatment, has left patients and clinicians …

… Thus, glutamine metabolism inhibition has been approached as a therapeutic target in
cancer for several decades. 6-diazo-5-oxo-L-norleucine (DON) is a broad glutamine antagonist …